Menopausal Hormone Therapy May Not Pose Breast Cancer Risk for Women With BRCA Mutations

Kathleen Medora / aacr - SAN ANTONIO – Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited mutations in the BRCA1 or BRCA2 genes, according to the results of a matched prospective analysis presented at the San …

AI Summary: A new analysis shows that menopausal hormone therapy does not increase breast cancer risk among women with inherited BRCA mutations, challenging long‐held concerns. This reassurance may help guide decision‐making for patients weighing their treatment options.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Ultra-endurance running rapidly damages and ages red blood cells / 3 months

NYC nurses’ strikes largely settle while one major walkout stays active / 3 months

High ultraprocessed food intake linked to increased cancer mortality / 3 months

Plastic surgeons recommend delaying gender‐affirming surgery until age 19 / 3 months

Snow Shoveling Raises Heart Risk Warning Amid Winter Storm / 4 months

Kaiser Permanente workers strike in CA and HI intensifies labor tensions / 4 months

It's freezing cold and you've lost power: Follow emergency doctor guidelines immediately / 4 months